India’s pharmaceutical industry is one of the industry leaders in 2024, researching and developing new solutions for the world’s critical health issues. This year mainly focused on redefining patient care with advanced approaches such as AI-driven...

India's status as the "pharmacy of the world" is based on its ability to create drug details and nonexclusive medications. Be that as it may, this standing lays on a tricky establishment, with roughly 70% of its Dynamic Drug Fixings (APIs) obtained..

Alembic Pharmaceuticals has received final approval from the US FDA for its generic Diltiazem Hydrochloride extended-release capsules, which are indicated for the treatment of hypertension. The capsule's anticipated market size was USD 105.3...

Lindy Biosciences, a protein therapeutic formulations firm, has announced a partnership with Novartis Pharmaceuticals to focus more on evolving drugs from Novartis to subcutaneous injections by using their micro classification suspension...

Owing to the direct impact of its products on public health & safety, the pharma sector operates within a highly regulated environment

A few months ago, lawmakers in Europe signed off on an update to the urban waste water treatment directive